Oct4A is a transcription factor, suppression of which is associated with decreased expression of integrin β1, α5, and α2 subunits leading to diminished adhesion of tumor cells to collagen and fibronectin, decreased levels of MMP-2, and certain markers. The gene discussed is FN1; the disease is neoplasm.